InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume $4.40 +0.26 (+6.28%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends InMed Pharmaceuticals Short Interest DataInMed Pharmaceuticals (INM) has a short interest of 12,800 shares. This marks a -50.58% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 113,510 shares to cover all short positions.Current Short Interest12,800 sharesPrevious Short Interest25,900 sharesChange Vs. Previous Month-50.58%Dollar Volume Sold Short$54,912.00Short Interest Ratio0.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares718,000 sharesPercentage of Shares Shorted1.78%Today's Trading Volume40,444 sharesAverage Trading Volume113,510 sharesToday's Volume Vs. Average36% Short Selling InMed Pharmaceuticals? Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINM Short Interest Over TimeINM Days to Cover Over TimeINM Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> InMed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202412,800 shares $54,912.00 -50.6%N/A0.3 $4.29 11/15/202425,900 shares $110,852.00 -77.6%N/A0.5 $4.28 10/31/2024115,500 shares $30,711.45 +188.8%N/A0 $0.27 10/15/202440,000 shares $8,760.00 -57.1%N/A0 $0.22 9/30/202493,200 shares $22,088.40 -82.6%N/A0 $0.24 9/15/2024534,900 shares $139,822.86 +55.3%N/A0.1 $0.26 Get the Latest News and Ratings for INM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024344,500 shares $122,263.05 +818.7%N/A0 $0.35 8/15/202437,500 shares $5,400.00 -85.2%N/A0 $0.14 7/31/2024253,200 shares $44,512.56 +85.2%N/A0.2 $0.18 7/15/2024136,700 shares $36,457.89 +61.4%N/A0.1 $0.27 6/30/202484,700 shares $22,487.85 -43.5%N/A0.1 $0.27 6/15/2024150,000 shares $34,005.00 +252.9%N/A0.2 $0.23 5/31/202442,500 shares $12,537.50 -44.6%N/A0.1 $0.30 5/15/202476,700 shares $21,015.34 -78.6%N/A0.2 $0.27 4/30/2024359,000 shares $96,571.00 +213.5%N/A0.9 $0.27 4/15/2024114,500 shares $36,491.15 +1,011.7%N/A0.3 $0.32 3/31/202410,300 shares $3,749.20 -81.9%N/A0 $0.36 3/15/202457,000 shares $20,520.00 -13.9%N/A0.3 $0.36 2/29/202466,200 shares $27,473.00 -52.1%N/A0.3 $0.42 2/15/2024138,300 shares $47,990.10 +244.9%N/A0.7 $0.35 1/31/202440,100 shares $14,431.99 -43.4%N/A0.2 $0.36 1/15/202470,800 shares $27,081.00 -47.2%N/A0 $0.38 12/31/2023134,000 shares $55,744.00 +1,213.7%N/A0.1 $0.42 12/15/202310,200 shares $3,672.00 -65.9%N/A0 $0.36 11/30/202329,900 shares $13,156.00 +510.2%N/A0 $0.44 11/15/20234,900 shares $1,989.40 -74.1%N/A0 $0.41 10/31/202318,900 shares $9,143.82 +339.5%N/A0 $0.48 10/15/20234,300 shares $2,743.40 +377.8%N/A0 $0.64 9/30/2023900 shares $629.91 -90.1%N/A0 $0.70 9/15/20239,100 shares $7,683.13 -65.4%N/A0.2 $0.84 8/31/202326,300 shares $21,592.30 +64.4%N/A0.5 $0.82 8/15/202316,000 shares $14,961.60 -61.5%N/A0.2 $0.94 7/31/202341,500 shares $46,480.00 +112.8%N/A0.5 $1.12 7/15/202319,500 shares $18,721.95 +2.6%N/A0.2 $0.96 6/30/202319,000 shares $17,480.00 -63.2%N/A0.2 $0.92 6/15/202351,600 shares $65,532.00 +4.7%N/A0.4 $1.27 5/31/202349,300 shares $66,062.00 -24.0%N/A0.1 $1.34 5/15/202364,900 shares $75,284.00 -30.8%N/A0.1 $1.16 4/30/202393,800 shares $112,560.00 -25.7%N/A0.2 $1.20 4/15/2023126,300 shares $157,875.00 +3.8%N/A0.2 $1.25Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/2023121,700 shares $131,436.00 -27.7%N/A0.2 $1.08 3/15/2023168,400 shares $178,504.00 +194.9%N/A0.2 $1.06 2/28/202357,100 shares $75,943.00 -15.8%N/A0.1 $1.33 2/15/202367,800 shares $113,226.00 -7.6%N/A0.1 $1.67 1/31/202373,400 shares $135,056.00 -75.4%N/A0.1 $1.84 1/15/2023297,800 shares $562,842.00 +443.4%3.8%0.3 $1.89 12/30/202254,800 shares $110,696.00 +13.0%0.7%0.1 $2.02 12/15/202248,500 shares $90,210.00 +62.8%0.6%0.1 $1.86 11/30/202229,800 shares $78,970.00 +223.9%0.4%0 $2.65 11/15/20229,200 shares $25,576.00 -32.9%0.1%0 $2.78 10/31/202213,700 shares $41,785.00 +121.0%0.2%0 $3.05 10/15/20226,200 shares $32,922.00 -83.9%0.1%0 $5.31 9/30/202238,600 shares $254,516.82 -57.3%0.5%0 $6.59 9/15/202290,300 shares $867,783.00 +12,800.0%1.2%0.1 $9.61 8/31/2022700 shares $4,165.00 -89.4%N/A0 $5.95 8/15/20226,600 shares $2,571.36 -62.5%0.1%0 $0.39 7/31/202217,600 shares $6,864.00 -18.9%0.2%0.1 $0.39 7/15/202221,700 shares $8,029.00 +6.4%0.3%0.1 $0.37 6/30/202220,400 shares $9,596.16 -80.1%0.3%0.1 $0.47 6/15/2022102,300 shares $53,400.60 +47.6%1.3%0.5 $0.52 5/31/202269,300 shares $53,361.00 -29.4%0.9%0.3 $0.77 5/15/202298,100 shares $81,423.00 -34.3%1.3%0.5 $0.83 4/30/2022149,300 shares $135,863.00 -8.7%1.9%0.7 $0.91 4/15/2022163,600 shares $142,806.44 +34.1%2.1%0.8 $0.87 3/31/2022122,000 shares $115,009.40 +114.4%1.6%0.9 $0.94 3/15/202256,900 shares $41,024.90 -35.3%0.7%0.6 $0.72 2/28/202287,900 shares $82,819.38 +2.6%1.1%0.8 $0.94 2/15/202285,700 shares $99,412.00 -2.7%1.1%0.3 $1.16 1/31/202288,100 shares $106,601.00 -15.7%1.1%0 $1.21 1/15/2022104,500 shares $129,580.00 +74.5%1.3%0 $1.24 12/31/202159,900 shares $78,469.00 -8.4%0.8%0 $1.31 12/15/202165,400 shares $96,792.00 -56.5%0.8%0 $1.48 11/30/2021150,400 shares $285,760.00 +69.9%1.9%0.1 $1.90 11/15/202188,500 shares $118,590.00 -19.7%1.1%0 $1.34 10/29/2021110,200 shares $168,055.00 +69.3%1.4%0.2 $1.53 10/15/202165,100 shares $91,140.00 -2.5%0.8%0.1 $1.40 9/30/202166,800 shares $116,900.00 +189.2%0.8%0.3 $1.75 9/15/202123,100 shares $47,553.66 +216.4%0.3%0.2 $2.06 8/31/20217,300 shares $16,133.00 -92.4%0.1%0.1 $2.21 8/13/202196,600 shares $231,840.00 -47.8%1.2%1.4 $2.40 7/30/2021185,100 shares $516,429.00 +98.2%2.3%2.6 $2.79 7/15/202193,400 shares $249,378.00 +396.8%1.2%1.3 $2.67 6/30/202118,800 shares $59,784.00 +37.2%0.2%0.2 $3.18 6/15/202113,700 shares $39,045.00 -2.8%0.2%0.2 $2.85 5/28/202114,100 shares $41,595.00 +30.6%0.2%0.2 $2.95 5/14/202110,800 shares $30,348.00 -90.7%0.1%0.1 $2.81 4/30/2021115,800 shares $431,934.00 -14.7%1.5%0.7 $3.73 4/15/2021135,800 shares $435,918.00 -64.8%1.7%0.7 $3.21 3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13 3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37 2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35 1/29/2021138,400 shares $546,693.84 +63.2%2.0%0.6 $3.95 1/15/202184,800 shares $367,184.00 No Change1.2%0.7 $4.33 INM Short Interest - Frequently Asked Questions What is InMed Pharmaceuticals' current short interest? Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 12,800 shares of INM short. Learn More on InMed Pharmaceuticals' current short interest. Is InMed Pharmaceuticals' short interest increasing or decreasing? InMed Pharmaceuticals saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 12,800 shares, a decrease of 50.6% from the previous total of 25,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InMed Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: NRx Pharmaceuticals, Inc. (6.36%), Cara Therapeutics, Inc. (1.26%), Acurx Pharmaceuticals, Inc. (3.22%), TherapeuticsMD, Inc. (0.19%), HCW Biologics Inc. (0.65%), Marinus Pharmaceuticals, Inc. (7.94%), PharmaCyte Biotech, Inc. (0.75%), Aspira Women's Health Inc. (4.33%), Sol-Gel Technologies Ltd. (0.70%), ANEW Medical, Inc. (1.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short InMed Pharmaceuticals stock? Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading up $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InMed Pharmaceuticals? A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further. How often is InMed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies NRx Pharmaceuticals Short Interest Cara Therapeutics Short Interest Acurx Pharmaceuticals Short Interest TherapeuticsMD Short Interest HCW Biologics Short Interest Marinus Pharmaceuticals Short Interest PharmaCyte Biotech Short Interest Aspira Women's Health Short Interest Sol-Gel Technologies Short Interest ANEW Medical Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
